100 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
3320
China Resources Pharmaceutical Group
HK$5.231.2%9.6%HK$32.9bHK$7.21PE8.1xE6.9%3.4%
3320
China Resources Pharmaceutical Group
HK$5.231.2%9.6%HK$32.9bHK$7.21PE8.1xE6.9%3.4%
3320
China Resources Pharmaceutical Group
HK$5.231.2%9.6%HK$32.9bHK$7.21PE8.1xE6.9%3.4%
512
Grand Pharmaceutical Group
HK$4.22-1.4%26.7%HK$14.8bHK$6.63PE6.1xE2.3%6.2%
2487
Cutia Therapeutics
HK$4.367.9%-32.9%HK$1.4bHK$14.61PS6.5xE49.4%n/a
1548
Genscript Biotech
HK$10.681.3%-16.8%HK$22.9bHK$22.72PS2.9xE111.3%0%
6160
BeiGene
HK$138.205.4%63.8%HK$24.0bHK$174.07PS7.4xE64.6%n/a
2877
China Shineway Pharmaceutical Group
HK$8.280%n/aHK$6.3bHK$13.01PE5.3xE5.5%6.8%
2877
China Shineway Pharmaceutical Group
HK$8.280%n/aHK$6.3bHK$13.01PE5.3xE5.5%6.8%
1681
Consun Pharmaceutical Group
HK$7.870%48.5%HK$6.5bHK$10.20PE7.3xE14.7%7.4%
1530
3SBio
HK$6.01-2.1%3.4%HK$14.2bHK$8.40PE7.9xE16.2%4.0%
3933
United Laboratories International Holdings
HK$11.541.2%67.0%HK$21.0bHK$12.11PE6.7xE5.2%5.2%
1548
Genscript Biotech
HK$10.681.3%-16.8%HK$22.9bHK$22.72PS2.9xE111.3%0%
9995
RemeGen
HK$13.28-1.6%-18.8%HK$13.1bHK$25.03PS4.4xE51.9%n/a
2487
Cutia Therapeutics
HK$4.367.9%-32.9%HK$1.4bHK$14.61PS6.5xE49.4%n/a
9995
RemeGen
HK$13.28-1.6%-18.8%HK$13.1bHK$25.03PS4.4xE51.9%n/a
2126
JW (Cayman) Therapeutics
HK$1.390.7%-13.7%HK$562.4mHK$2.40PS3xE-1.8%n/a
512
Grand Pharmaceutical Group
HK$4.22-1.4%26.7%HK$14.8bHK$6.63PE6.1xE2.3%6.2%
3933
United Laboratories International Holdings
HK$11.541.2%67.0%HK$21.0bHK$12.11PE6.7xE5.2%5.2%
1530
3SBio
HK$6.01-2.1%3.4%HK$14.2bHK$8.40PE7.9xE16.2%4.0%
1548
Genscript Biotech
HK$10.681.3%-16.8%HK$22.9bHK$22.72PS2.9xE111.3%0%
2877
China Shineway Pharmaceutical Group
HK$8.280%6.0%HK$6.3bHK$13.01PE5.3xE5.5%6.8%
9995
RemeGen
HK$13.28-1.6%-18.8%HK$13.1bHK$25.03PS4.4xE51.9%n/a
1530
3SBio
HK$6.01-2.1%3.4%HK$14.2bHK$8.40PE7.9xE16.2%4.0%
Page 1 of 5